PM&R
Volume 1, Issue 3, Supplement , Pages S4-S12 , March 2009

Stroke and Neurodegenerative Disorders: 1. Stroke Management in the Acute Care Setting

  • Cara Camiolo Reddy, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, University of Pittsburgh Medical Center, 3471 Fifth Ave, LKB Ste 201, Pittsburgh, PA 15213†
    • Corresponding Author InformationAddress correspondence to: C.C.R.
    • ,
  • Alex Moroz, MD

      Affiliations

    • NYU School of Medicine, Rusk Institute of Rehabilitation Medicine, New York, NY‡
    • ,
  • Steven R. Edgley, MD

      Affiliations

    • University of Utah, Salt Lake City, UT§
    • ,
  • Henry L. Lew, MD, PhD

      Affiliations

    • Harvard Medical School, VA Boston Healthcare System, Physical Medicine and Rehabilitation Service, Boston, MA
    • ,
  • John Chae, MD

      Affiliations

    • Case Western Reserve University, MetroHealth Medical Center, Department of Physical Medicine and Rehabilitation, Cleveland, OH∥
    • ,
  • Lisa A. Lombard, MD

      Affiliations

    • Santa Clara Valley Medical Center, Department of Physical Medicine and Rehabilitation, San Jose, CA#

References 

  1. Audebert HJ, Kukla C, Vatankhah B, et al. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke. 2006;37:1822–1827
  2. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of patients with ischemic stroke. Stroke. 2007;38:1655–1711
  3. Goldstein LB, Samsa GP. Reliability of the NIH Stroke Scale (Extension to non-neurologists in the context of a clinical trial). Stroke. 1997;8:307–310
  4. Adams HP, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53:126–131
  5. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669–774
  6. Mullins ME. Modern emergent stroke imaging: pearls, protocols, and pitfalls. Radiol Clin N Am. 2006;44:41–62
  7. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587
  8. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;37:1432–1438
  9. Ng PP, Higashida RT, Cullen SP, Malek R, Dowd CF, Halbach VV. Intra-arterial thrombolysis trials in acute ischemic stroke. J Vasc Intervent Radiol. 2004;15(1 Pt 2):S77–S85
  10. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309–315
  11. Curry WT, Sethi MK, Ogilvy CS, Carter BS. Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction. Neurosurgery. 2005;56:681–692
  12. Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction. Stroke. 2004;35:539–543
  13. Mayer S. Hemicraniectomy: a second chance on life for patient with space-occupying MCA infarction. Stroke. 2007;38:2410–2412
  14. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of intracerebral hemorrhage in adults. Stroke. 2007;38:2001–2023
  15. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–993
  16. Qureshi AI, Mohammad YM, Yahia AM, et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med. 2005;20:34–42
  17. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35:1364–1367
  18. Morgenstern LB, Frankowski RF, Shedden P, Pasteur W, Grotta JC. Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology. 1998;5:1359–1363
  19. Mendelow AD, Unterberg A. Surgical treatment of intracerebral haemorrhage. Curr Opin Crit Care. 2007;13:169–174
  20. Brust JCM. Cerebral infarction. In:  Rowland LP editors. Merritt's neurology. 11th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2000;
  21. Fisher CM. Lacunar strokes and infarcts: a review. Neurology. 1982;32:871–876
  22. Gorman MJ, Dafer R, Levine SR. Ataxic hemiparesis: critical appraisal of a lacunar syndrome. Stroke. 1998;29:2549–2555
  23. Sacco S, Marini C, Totaro R, et al. A population-based study of the incidence and prognosis of lacunar stroke. Neurology. 2006;66:1335–1338
  24. Mast H, Thompson JL, Lee SH, Mohr JP, Sacco RL. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. Stroke. 1995;26:30–33
  25. Jackson C, Sudlow C. Are lacunar strokes really different?. Stroke. 2005;36:891–901
  26. Medical Inpatient Rehabilitation Criteria Task Force. John L. Melvin, Chairman (Standards for assessing medical appropriateness criteria for admitting patients to rehabilitation hospitals or units). Chicago, IL: American Academy of Physical Medicine and Rehabilition; September 2006;http://www.aapmr.org/hpl/legislation/mirc.htmAccessed March 1, 2008
  27. Seenan P, Long M, Langhorne P. Stroke units in their natural habitat ([Systematic review of observational studies]). Stroke. 2007;38:1886–1892
  28. Jorgensen HS, Nakayama H, Raaschou HO, Larsen K, Hubbe P, Olsen TS. The effect of a stroke unit: reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. Stroke. 1995;26:1178–1182
  29. De Wit L, Putman K, Schuback B, et al. Motor and functional recovery after stroke: a comparison of 4 European rehabilitation centers. Stroke. 2007;38:2101–2107
  30. Kramer AM, Steiner JF, Schlenker RE, et al. Outcomes and costs after hip fracture and stroke: a comparison of rehabilitation settings. JAMA. 1997;277:396–404
  31. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomized trials of organized inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151–1159
  32. Mayo NE, Wood-Dauphinee S, Cote R, et al. There's no place like home: an evaluation of early supported discharge for stroke. Stroke. 2000;31:1016–1023
  33. Anderson C, Rubenach S, Mhurchu CN, Clark M, Spencer C, Winsor A. Home or hospital for stroke rehabilitation? (Results of a randomized controlled trial: health outcomes at 6 months). Stroke. 2000;31:1024–1031
  34. Kozlowski DA, James DC, Schallert T. Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions. J Neuroscience. 1996;16:4776–4786
  35. DeBow SB, McKenna JE, Kolb B, Colbourne F. Immediate constraint-induced movement therapy causes local hyperthermia that exacerbates cerebral cortical injury in rats. Can J Physiol Pharmacol. 2004;82:231–237
  36. Biernaskie J, Chernenko G, Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neuroscience. 2004;24:1245–1254
  37. Sacco RL, Prabhakaran S, Thompson JL, et al. WARSS Investigators Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis. 2006;22:4–12
  38. Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J. Statins and stroke prevention. Cerebrovasc Dis. 2007;24:170–182
  39. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–1718
  40. Amarenco P, Bougousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–559
  41. van Gijn J. The PROGRESS Trial: preventing strokes by lowering blood pressure in patients with cerebral ischemia (Emerging therapies: critique of an important advance). Stroke. 2002;33:319–320
  42. Dincer HE, O'Neill W. Deleterious effects of sleep-disorded breathing on the heart and vascular system. Respiration. 2006;73:124–130
  43. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis (North American Symptomatic Carotid Endarterectomy Trial Collaborators). N Engl J Med. 1998;339:1415–1425
  44. Blumenfeld H. Neuroanatomy through clinical cases. Sunderland, MA: Sinauer; 2002;

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

PII: S1934-1482(09)00113-0

doi: 10.1016/j.pmrj.2009.01.015

PM&R
Volume 1, Issue 3, Supplement , Pages S4-S12 , March 2009

Article Tools

* Image Usage & Resolution